Variable Interest Entities - Summary of Primary Beneficiary for VIEs Consolidated Under the VIE Model (Detail) |
12 Months Ended | |
|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Perception Neuroscience Holdings, Inc. [Member] | ||
| Variable Interest Entity [Line Items] | ||
| Relationship | Controlled VIE | Controlled VIE |
| Date Control Obtained | November 2018 | |
| Ownership % | 59.20% | 59.20% |
| Recognify Life Sciences, Inc. [Member] | ||
| Variable Interest Entity [Line Items] | ||
| Relationship | Controlled VIE | Controlled VIE |
| Date Control Obtained | November 2020 | |
| Ownership % | 51.90% | 51.90% |
| X | ||||||||||
- Definition Date of control obtained. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Describes the relationship and business conducted between the reporting entity and the Variable Interest Entity (VIE). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|